Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Scheinberg

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Cancer Immunology Research|September 30, 2016
Kinase Regulation of Human MHC Class I Molecule Expression on Cancer CellsElliott J Brea, Claire Y Oh, Eusebio Manchado, et al.
Cancer Immunology Research|July 3, 2024
Augmenting CAR T-cell Functions with LIGHTWinson Cai, Kento Tanaka, Xiaoli Mi, et al.
Theranostics|November 1, 2023
Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applicationsKeifer Kurtz, Laura Eibler, Megan M Dacek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
(124)I-huA33 antibody PET of colorectal cancerJorge A Carrasquillo, Neeta Pandit-Taskar, Joseph A O'Donoghue, et al.
Journal of the National Cancer Institute|May 14, 2010
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growthOlaf Penack, Erik Henke, David Suh, et al.
Theranostics|October 14, 2020
Alpha radioimmunotherapy using <sup>225</sup>Ac-proteus-DOTA for solid tumors - safety at curative dosesSarah M Cheal, Michael R McDevitt, Brian H Santich, et al.
Nature Medicine|April 28, 2022
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CASmita S Chandran, Jiaqi Ma, Martin G Klatt, et al.
Cancer Discovery|January 10, 2020
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaPatrizia Mondello, Saber Tadros, Matt Teater, et al.
Plos Pathogens|January 8, 2024
Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIPAyana E Morales, Ruby Gumenick, Caitlyn M Genovese, et al.
Genome Biology|November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signaturesYasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Cancer Immunology Research|September 30, 2016
Kinase Regulation of Human MHC Class I Molecule Expression on Cancer CellsElliott J Brea, Claire Y Oh, Eusebio Manchado, et al.
Cancer Immunology Research|July 3, 2024
Augmenting CAR T-cell Functions with LIGHTWinson Cai, Kento Tanaka, Xiaoli Mi, et al.
Theranostics|November 1, 2023
Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applicationsKeifer Kurtz, Laura Eibler, Megan M Dacek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2011
(124)I-huA33 antibody PET of colorectal cancerJorge A Carrasquillo, Neeta Pandit-Taskar, Joseph A O'Donoghue, et al.
Journal of the National Cancer Institute|May 14, 2010
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growthOlaf Penack, Erik Henke, David Suh, et al.
Theranostics|October 14, 2020
Alpha radioimmunotherapy using <sup>225</sup>Ac-proteus-DOTA for solid tumors - safety at curative dosesSarah M Cheal, Michael R McDevitt, Brian H Santich, et al.
Nature Medicine|April 28, 2022
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CASmita S Chandran, Jiaqi Ma, Martin G Klatt, et al.
Cancer Discovery|January 10, 2020
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in LymphomaPatrizia Mondello, Saber Tadros, Matt Teater, et al.
Plos Pathogens|January 8, 2024
Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIPAyana E Morales, Ruby Gumenick, Caitlyn M Genovese, et al.
Genome Biology|November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signaturesYasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Pageof 17